Biome Australia (ASX:BIO) 3-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:BIO Biome Australia Ltd ASX:BIO
29 GF Score
Price A$0.40
GF Value A$0.71
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Biome Australia 3-Year EBITDA Growth Rate?

Biome Australia ASX:BIO -4.76% 29 3-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates ASX:BIO with a GF Score™ of 29/100 and a GF Value™ of A$0.71 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,677 Consumer Packaged Goods companies, Biome Australia ranks worse than 59630.23% on this metric.

Biome Australia's EBITDA per Share for the six months ended in Jun. 2026 was A$0.00.

During the past 12 months, Biome Australia's average EBITDA Per Share Growth Rate was 133.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Biome Australia  (ASX:BIO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Biome Australia 3-Year EBITDA Growth Rate Related Terms

ASX:BIO vs KHC, GIS: 3-Year EBITDA Growth Rate Comparison

For the Packaged Foods subindustry, Biome Australia's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biome Australia 3-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biome Australia's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Biome Australia's 3-Year EBITDA Growth Rate falls into.


ASX:BIO
29GF Score
Biome Australia Ltd ASX:BIO
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biome Australia 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Biome Australia (ASX:BIO) has a 3-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Biome Australia and its competitors. According to the industry distribution chart, Biome Australia ranks #999999 out of 1677 companies in the Consumer Packaged Goods industry.
Is Biome Australia's 3-Year EBITDA Growth Rate too high?
Biome Australia's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Biome Australia ranks #999999 out of 1677 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Biome Australia has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biome Australia's 3-Year EBITDA Growth Rate compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Biome Australia ranks #999999 out of 1677 companies for 3-Year EBITDA Growth Rate. This places Biome Australia in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EBITDA Growth Rate among Consumer Packaged Goods companies is 8.00, based on 1,677 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Biome Australia and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EBITDA Growth Rate is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biome Australia's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biome Australia stock overvalued right now?
Based on GuruFocus' analysis, Biome Australia (ASX:BIO) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.71, compared to a current price of A$0.40 — trading 43.7% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Biome Australia's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Biome Australia (ASX:BIO), the current 3-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biome Australia (ASX:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biome Australia stock appears to be undervalued. The current stock price of A$0.40 is trading 43.7% below its estimated GF Value™ of A$0.71. GuruFocus considers Biome Australia to be Possible Value Trap.

Key valuation signals for ASX:BIO:

  • 3-Year EBITDA Growth Rate: 0.00%
  • GF Value™: A$0.71 vs. price of A$0.40 (43.7% below fair value)
  • GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the ASX:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biome Australia Business Description

Address 192-194 Johnston Street, Collingwood, VIC, AUS, 3066
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
29GF Score

Get the complete analysis for ASX:BIO

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.40
Price
A$0.71
GF Value